The invitation here is to think reasonably and realistically. Try it. — tim wood
So the contingent/indeterminate v. the apodictic. 2+2=4 and that's an end of it, and somtimes the Germans are better and sometimes the Brazilians. The question here being if there is anything apodictic about Covid vaccination. And I think there is. — tim wood
But there are people out there pushing the odds against you and yours for no decent, good, or reasonable reason. I'm not at all sure anger should be the animating spirit of response, though it be often a clue, but perhaps a more reasoned attention that at some point, as required, directs and insists and imposes. — tim wood
Indeed I hold it is. There is the issue of the greater good against a pandemic. No question about either - no reasonable question, at any rate. The pandemic is real, the benefits of the vaccine are demonstrated. And the validity of general vaccination as a strategy against disease well-established. The argument is over, and was over when it began. All that remains is the whining, and the news routinely reports that ceases when the whiner or his get sick or die. — tim wood
Indeed I hold it is. There is the issue of the greater good against a pandemic. No question about either - no reasonable question, at any rate. The pandemic is real, the benefits of the vaccine are demonstrated. And the validity of general vaccination as a strategy against disease well-established. The argument is over, and was over when it began. All that remains is the whining, and the news routinely reports that ceases when the whiner or his get sick or die.
Do you want the vaccine to be perfect? It isn't, and the point is that it does not have to be. Is a bulletproof vest perfect protection from a shooter? No. But does that mean you should not wear one? Certainly not! — tim wood
So the contingent/indeterminate v. the apodictic. 2+2=4 and that's an end of it, and somtimes the Germans are better and sometimes the Brazilians. The question here being if there is anything apodictic about Covid vaccination. And I think there is. And thus anti-vaxxing is a taking from me for no good reason something that is mine. And that leaves no room for respect, nor is fair. — tim wood
You question the reality of the pandemic? You question the efficacy of the vaccine(s)? You question the general hazard to the well-being of the community and its several members that unvaccinated people represent? — tim wood
The physician, as agent for the state acting in the interests of persons refusing care, the state will provide the care — tim wood
a general surety that the FDA would not allow vaccines onto the market which endangered people by severely lacking efficacy, — Michael Zwingli
On June 7, the FDA approved aducanumab for the treatment of Alzheimer's disease. The drug received accelerated approval because it showed it could reduce the rate of amyloid plaque on scans. What remains uncertain is whether this reduction in plaque means Alzheimer's patients live longer or better lives -- and notably, the totality of the clinical trial data do not show that. Moreover, the drug has various side effects and a whopping price tag: $56,000 a year.
In response to the FDA's approval, three members of the Peripheral and Central Nervous System Drugs Advisory Committee who opposed approval of the drug, quit the panel in protest. Aaron Kesselheim, MD, JD, MPH, a Harvard professor called the drug "problematic," and argued that there was little evidence it would help patients. Writing in The Atlantic, Nicholas Bagley, JD, and Rachel Sacks, JD, MPH, estimate that if the drug is prescribed to just one-third of eligible patients, it would cost Medicare $112 billion a year -- a massive figure that dwarfs any other medication.
Last year the FDA said it was “committed to use an advisory committee composed of independent experts to ensure deliberations about authorisation or licensure are transparent for the public.”1 But in a statement, the FDA told The BMJ that it did not believe a meeting was necessary ahead of the expected granting of full approval.
Kim Witczak, a drug safety advocate who serves as a consumer representative on the FDA’s Psychopharmacologic Drugs Advisory Committee,4 said the decision removed an important mechanism for scrutinising the data.
Diana Zuckerman, president of the National Center for Health Research, who has also spoken at recent VRBPAC meetings, told The BMJ, “It’s obvious that the FDA has no intention of hearing anyone else’s opinion.
Get involved in philosophical discussions about knowledge, truth, language, consciousness, science, politics, religion, logic and mathematics, art, history, and lots more. No ads, no clutter, and very little agreement — just fascinating conversations.